Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow 2021-08-09 19:30
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users 2021-08-09 18:02
Thailand's Jan-June Investment Applications Reach USD12 billion, as FDI Quadruple, E&E and Medical Sectors Continue to Expand, BOI says 2021-08-09 15:35
Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets 2021-08-09 08:30
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne 2021-08-09 08:30
Innovent Announces the Establishment of the Scientific Advisory Board 2021-08-09 08:04
Insightec Announces Seoul National University Hospital Is Installing Exablate Neuro Platform 2021-08-09 08:00
NUH's Smallest Surviving Baby Discharged Well to Home 2021-08-07 15:00
FibroBiologics Announces Inaugural Board of Directors 2021-08-06 22:01
Endurance Longevity Announces Positive Profit Alert for Interim Results 2021 and Other Exciting Business Updates 2021-08-06 20:02
ImmVira's MVR-T3011 Obtained NMPA's Approval for Intravenous Administration (IV) Phase I Clinical Trial 2021-08-06 19:50
AI and Big Data Join Hands to Assist Physicians in Diagnosis and Reporting 2021-08-06 17:00
ORI Capital's Portfolio Company Pillar Receives FDA Premarket Approval for its oncoReveal(TM) Dx Lung and Colon Cancer Test 2021-08-06 12:56
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China 2021-08-06 09:39
SURGLASSES' SPINE NAVIGATION SYSTEM CADUCEUS S - An innovation greatly influencing minimally invasive surgeries 2021-08-06 08:00
Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology 2021-08-06 08:00
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination 2021-08-06 05:03
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine 2021-08-06 04:41
Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization 2021-08-06 02:00
Brii Biosciences Announces the Completion of Enrollment in the Phase 3 National Institutes of Health (NIH) ACTIV-2 Trial, Evaluating the BRII-196 and BRII-198 Monoclonal Neutralizing Antibody Combination for the Treatment of COVID-19 2021-08-05 22:46
1 419 420 421 422 423 953